A recent study has indicated that the nuclear BNIP3 forms a complex with histone deacetylase 1 (HDAC1) and PTB-associating splicing factor (PSF) to down-regulate AIF expression in glioma cells, leading to their resistance to temozolomide-induced cell death [23]. Here, BNIP3 is linked to central nervous system cancer.